News

The meeting was with a startup created by Flatiron Health veterans Josh Haimson and Ben Birnbaum. The duo had built the first ...
Vinay Prasad, an academic and fierce critic of the medical mainstream, has been chosen to be the next director of the FDA ...
“Potential exposure to these substances is still quite small, thank goodness,” Jim Crotty, who served for over a decade in ...
I love trying the local ice cream when I visit a different city. I recently had the best ice cream experience of my life at ...
No amount of data showing that RFK Jr. is wrong will change his mind,” vaccine advocate Paul Offit writes in an open letter ...
Trump cuts are hitting the National Cancer Institute, affecting a hotline for patients, cancer.gov, advisory panels, clinical ...
Attorney General Pam Bondi's claim that fentanyl seizures saved 258 million lives follows a long line of dubious claims from ...
There are currently no drugs approved that lower levels of 'remnant cholesterol' associated with cardiovascular risk.
Now is the time for the biotechnology sector to ask for big changes to the FDA, NIH, reimbursement, intellectual property and ...
I recently sat with a young scientist in my office, tears in her eyes, who was asking for advice: Her grant had been canceled ...
Vinay Prasad will be the next director of the FDA's Center for Biologics Evaluation and Research, after Peter Marks was ...
Investors reacted negatively to the news. The company’s stock fell more than 16% yesterday. It’s also a setback in ...